Ebrahimi E, Shirkoohi R. What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Arch Breast Cancer [Internet]. 2018 Nov. 30 [cited 2024 Jul. 19];:148-9. Available from: https://archbreastcancer.com/index.php/abc/article/view/205